Trial intelligence / Profile preview

LMWH for Pulmonary Microthrombosis in Childhood Pneumonia

NCT04778917Phase 4

Key facts

Status
Completed
Start
Dec 2014
Primary completion
Jul 2017
Countries
1
Sponsor
Capital Institute of Pediatrics
Modality
Recombinant Proteins and Enzymes
Conditions
pneumonia
01

Overview

Phase 4, randomised, single-blind trial of low molecular weight heparin calcium in pneumonia (4 arms), sponsored by Capital Institute of Pediatrics. Primary endpoints: Lung imaging absorption improvement time after treatment at 1 month, Time to improve cough symptoms at 2 weeks and 2 more. Started Dec 2014; status: completed.

02

Design

4 arms
Study design
RandomizedSingle-blind
  • Conventional (High D-dimer)

    Conventional treatment without LMWH in patients with D-dimer >= 500 ug/L.

  • Low Dose LMWH

    LMWH Calcium 50-100 units/kg/day in patients with D-dimer >= 500 ug/L.

  • High Dose LMWH

    LMWH Calcium 200 units/kg/day (100 units/kg BID) in patients with D-dimer >= 500 ug/L.

  • Conventional (Low D-dimer)

    Conventional treatment in patients with D-dimer < 500 ug/L.

03

Who it enrols

Children aged 28 days to 18 years with a clinical diagnosis of simple pneumonia. Patients with congenital heart disease, kidney disease, blood system diseases, paralysis, muscle tension, fracture, family history of thrombotic disease, indwelling central venous catheters, parenteral nutrition, neoplastic disease, or primary immunodeficiency disease are excluded.

04

Endpoints

Primary

  • Lung imaging absorption improvement time after treatment

  • Time to improve cough symptoms

  • Heat retreat time

  • The time to disappear rhonchus in the lungs

Secondary

  • Average hospital stay time

  • The degree of coagulation improvement

  • Differences in inflammation indicators in each group

Beyond the preview

Go deeper on NCT04778917.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04778917.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call